Paul Varosy, a cardiologist with the CU School of Medicine, compared the Lariat's approval process to that of the Watchman, another device targeting the left atrial appendage that received FDA approval in March.
CU’s Richard Johnson, author of The Sugar Fix, says “a mutation occurred” that increased the apelike creatures' sensitivity to fructose so that even small amounts were stored as fat.
CU’s Susan Boackle: “The best way to treat arthritis – and other rheumatic diseases – is to stop it in its tracks and find a cure. And we’re almost there"
CU’s Antonio Jimeno: “One of the reasons that anti-cancer immune therapies have been difficult to develop is that perhaps we haven’t had adequate models.”
CU’s Mark W. Geraci, a pulmonologist and lung cancer researcher, has been named the new chair of the Department of Medicine at the Indiana University School of Medicine, effective Aug. 24, 2015.
CU’s Todd Bull, a pulmonologist: “She had extremely severe disease — life-threatening.” UCH’s Pulmonary Hypertension Center was recently accredited as a Center for Comprehensive Care.
CU’s Wendy Kohrt: “The anecdotes we often hear about weight — there is real biology behind why it becomes more difficult for women to lose weight or to prevent gain after menopause than before.”
CU’s Amy Heubschmann: “People are more likely to be active if they find exercises that are personally rewarding, such as walking regularly or going to an exercise class.”
With an infusion of $1.5 million, CU’s Virginia Borges will lead the research to help find new treatments for young women and young mothers who have breast cancer.
CU’s Thomas Campbell, an HIV researcher: “This is the first human study of this antibody. It gives a strong signal that the people who are developing this approach should continue on with this type of investigation.”
CU’s Jason Persoff: "Edibles go through digestion, and it takes a while for that to happen. That can lead to a sustained high, and it also can have sustained side effects.”
CU's Holly Wyatt:"The app offers individuals a clear-cut end goal for weight loss and provides users with an important tool to activate and achieve a successful programme."
CU's Robert H. Eckel:"I think the public's completely confused. The right studies need to be done where the entire diet is prescribed and the only modification is in cholesterol content."
"What does it mean to a patient when you says it's OK to stop taking a medication?" asks CUs Jean Kutner, a professor in medicine.
CU’s Ross Camidge says the revolution in the last decade has been in diagnosing and treating cancer at the molecular level.